My Personal Therapeutics a London based biotechnology company announced today that it has completed technology licensing and secured initial funding to tranform cancer care. Investment was led by London based StartUp Funding Club and independent international investors.
Researchers have created fruit fly “avatars” that have helped to guide treatment for a man who had terminal colon cancer. The team genetically engineered flies that had the same mutations as the man’s tumor and then tested different drug combinations to see which ones kept the flies alive.
A group led by researchers at the Icahn School of Medicine at Mount Sinai has built a fruit fly model to develop a personalised therapy for a patient with treatment resistant metastatic KRAS-mutation colorectal cancer (CRC).